10,072 Shares in CVS Health Corporation $CVS Bought by Proficio Capital Partners LLC

Proficio Capital Partners LLC bought a new stake in CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 10,072 shares of the pharmacy operator’s stock, valued at approximately $1,042,000.

A number of other institutional investors also recently bought and sold shares of CVS. Elevation Wealth Partners LLC lifted its stake in CVS Health by 41.8% during the second quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 105 shares during the last quarter. Apella Capital LLC boosted its holdings in shares of CVS Health by 1.7% in the second quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock valued at $724,000 after acquiring an additional 117 shares during the period. CYBER HORNET ETFs LLC grew its position in shares of CVS Health by 4.1% during the third quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator’s stock worth $259,000 after acquiring an additional 134 shares during the last quarter. Northwestern Mutual Investment Management Company LLC grew its position in CVS Health by 0.3% during the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 40,560 shares of the pharmacy operator’s stock worth $3,219,000 after purchasing an additional 136 shares during the last quarter. Finally, CoreCap Advisors LLC increased its position in CVS Health by 4.2% in the 2nd quarter. CoreCap Advisors LLC now owns 3,481 shares of the pharmacy operator’s stock valued at $360,000 after acquiring an additional 139 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CVS has been the topic of several recent research reports. Royal Bank Of Canada boosted their price objective on shares of CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Sanford C. Bernstein boosted their target price on CVS Health from $94.00 to $106.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 12th. Piper Sandler reaffirmed an “overweight” rating on shares of CVS Health in a research note on Wednesday, August 26th. TD Cowen raised their price target on shares of CVS Health from $105.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Finally, Cantor Fitzgerald lifted their price objective on CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, July 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $107.17.

CVS Health Price Performance

Shares of NYSE CVS opened at $97.36 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The company has a market capitalization of $124.52 billion, a price-to-earnings ratio of 25.76, a PEG ratio of 0.92 and a beta of 0.59. The business has a 50-day moving average of $101.18 and a 200-day moving average of $89.82.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same period in the previous year, the company posted $1.81 EPS. CVS Health’s revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, equities analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s payout ratio is presently 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.